Comparison Chart Dimerix Limited

Stocks

DXB

AU000000DXB7

Biotechnology & Medical Research

Market Closed - Australian S.E. 02:10:31 2026-08-21 EDT			5-day change	1st Jan Change
0.3100 ^AUD	-4.62%		+5.08%	-43.64%

08-19	Dimerix Receives Initial $10 Million Upfront Payment Under Everest Medicines License Deal; Shares Gain 4%	MT
08-16	Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	DIMERIX LIMITED	Other Biotechnology & Medical Research	-4.62%	+5.08%	-43.64%	-31.87%	+1.64%	133M